retatrutide type 2 diabetes trial Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA New Triple-Action Drug Retatrutide Shows

Glycyrrhizin alleviates liver injury by precisely inhibiting the overactivation of this pathway in normal hepatocytes, which reverses cell cycle blockade and restores normal hepatocyte proliferation and function through downregulating p53/p21 and upregulating Cyclin D1, all without compromising the antitumor efficacy of gefitinib via the same pathway in cancer cells (Li et al., 2025)

Decreases adipocytes and produces collagen to increase skin elasticity

Its a simple habit that pays huge dividends in data integrity

Copper itself plays an important role in many normal functions in the body, which is why copper peptides have become a popular subject in cosmetic research

The putative alterations of 3- and 17-hydroxysteroid dehydrogenase, two key enzymes of steroidogenesis typically affected by CCs exposure, were studied along with the plasmatic concertation of testosterone

In animal models, oral BPC-157 reduced gut-ulcer lesions by up to 60% and accelerated tendon healing within two weeks